+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Cancer Screening Market by Technology, Age Group, Delivery Mode, End User - Global Forecast to 2030- Product Image
Breast Cancer Screening Market by Technology, Age Group, Delivery Mode, End User - Global Forecast to 2030- Product Image
Sale

Breast Cancer Screening Market by Technology, Age Group, Delivery Mode, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011427
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Breast Cancer Screening Market grew from USD 5.31 billion in 2024 to USD 5.69 billion in 2025. It is expected to continue growing at a CAGR of 6.86%, reaching USD 7.91 billion by 2030.

Setting the Scene for Breast Cancer Screening Evolution

The landscape of breast cancer screening is undergoing a profound transformation, driven by technological innovation, shifting patient demographics, and evolving healthcare policies. As detection methodologies advance, stakeholders across the value chain are presented with both unprecedented opportunities and complex challenges. This report opens by contextualizing the pivotal forces shaping the market, from emerging imaging modalities to the growing importance of personalized screening protocols.

Revolutionary Transitions Reshaping Screening Protocols

Over the past decade, the breast cancer screening arena has witnessed a radical convergence of digital technologies and patient-centric care models. Artificial intelligence-driven image analysis has moved from experimental stages into clinical practice, accelerating anomaly detection with greater precision. Concurrently, there has been a pronounced shift toward risk-based screening protocols that tailor frequency and modality to individual patient profiles. Telehealth platforms now facilitate remote risk assessment and even preliminary image review, reducing barriers for underserved populations.

This transformative phase extends to service delivery as well. Integrated diagnostic ecosystems that combine 3D tomosynthesis, contrast-enhanced magnetic resonance imaging, and molecular breast imaging are redefining diagnostic pathways. Healthcare providers are investing in interoperable data systems that streamline workflows, enable real-time collaboration among radiologists, and support advanced analytics. As the industry accelerates in this direction, the focus on early detection, reduced false-positive rates, and enhanced patient experience is becoming paramount, reshaping competitive dynamics and investment priorities worldwide.

Navigating the Ripple Effects of U.S. Tariff Adjustments

In 2025, the implementation of new U.S. tariffs on critical imaging components and contrast agents has introduced a fresh layer of complexity to procurement strategies. Equipment manufacturers and healthcare providers are contending with elevated import costs for specialized detectors, advanced MRI coils, and proprietary radiopharmaceuticals essential to molecular breast imaging. These cost pressures are manifesting in extended lead times, renegotiated supply contracts, and revised budget forecasts.

Healthcare systems are responding by diversifying their supplier portfolios, forging partnerships with domestic component producers, and accelerating in-house manufacturing capabilities where feasible. Budget reallocation toward technology upgrades now necessitates more rigorous cost-benefit analyses, compelling institutions to weigh the clinical advantages of cutting-edge modalities against the fiscal impact of tariff-inflated expenditures. As a result, the tariff environment is catalyzing a broader reassessment of total cost of ownership for imaging assets, while prompting innovative financing models such as shared equipment-as-a-service arrangements.

Unveiling Market Complexity through Segmentation Insight

The breast cancer screening market’s heterogeneity is reflected in the spectrum of technologies spanning two-dimensional mammography, three-dimensional tomosynthesis, magnetic resonance imaging, molecular breast imaging, thermography, and ultrasound. Within two-dimensional mammography, analog systems coexist alongside digital platforms that deliver higher-resolution images and streamlined integration with electronic health records. Magnetic resonance imaging bifurcates into contrast-enhanced protocols that heighten lesion visibility and non-contrast techniques favored for patients with contrast allergies or renal considerations. Molecular breast imaging deepens diagnostic capability through breast specific gamma imaging and scintimammography, each offering unique radiotracer applications for lesion characterization. Ultrasound’s rise in screening owes much to automated systems that augment reproducibility, complementing handheld devices prized for their portability and operator control.

Age-based stratification reveals distinct screening imperatives across patient cohorts. Individuals under forty often undergo ultrasound or MRI when clinical indication arises, whereas those aged forty to forty-nine may benefit from supplemental tomosynthesis alongside standard mammography. Women fifty to sixty-nine represent the largest screening base, driving widespread adoption of digital mammography and emerging modalities. Screening for seventy and above balances clinical benefit against comorbidity management, with non-invasive approaches like thermography gaining interest for lower physiological burden.

From a delivery model standpoint, cloud-based platforms-leveraging software as a service and web-enabled analytics-are enabling real-time image sharing and remote second opinions, while on-premise installations continue to serve facilities with stringent data sovereignty requirements. Finally, end-user differentiation spans ambulatory care centers seeking compact, high-throughput systems, specialty clinics focusing on risk-based screening programs, chain diagnostic centers optimizing workflow standardization, independent centers prioritizing cost efficiency, and hospitals balancing broad modality portfolios across private and public sectors.

Discerning Regional Pathways to Screening Excellence

Regional dynamics in breast cancer screening reflect complex ecosystem interactions and resource distributions. In the Americas, advanced healthcare infrastructure and early adoption of digital mammography and tomosynthesis have driven market leadership, yet disparities persist between urban centers and rural communities. Policy initiatives aimed at expanding coverage and incentivizing preventive care continue to shape screening participation rates.

Across Europe, Middle East & Africa, a mosaic of national screening programs coexists with nascent private sector offerings. Western European nations demonstrate mature reimbursement frameworks and high public awareness, while regions in the Middle East and Africa confront infrastructural limitations and workforce training challenges. This diversity fuels targeted investments in portable ultrasound and telehealth-enabled screening to reach under-screened populations.

In the Asia-Pacific corridor, rapid economic growth and rising healthcare expenditure underpin accelerating adoption of advanced modalities. Early adopters in Japan and Australia are pushing the envelope with contrast-enhanced MRI and molecular imaging, while emerging markets across Southeast Asia and India prioritize scalable, cost-effective ultrasound and digital mammography solutions. Collaborative initiatives among public and private stakeholders are driving capacity-building and technology transfer, reshaping regional screening paradigms.

Identifying Leading Innovators and Disruptors

The competitive landscape in breast cancer screening is defined by the interplay of established imaging giants and agile technology innovators. Key players are intensifying R&D investment to refine artificial intelligence algorithms for lesion detection and risk stratification. Strategic alliances between equipment manufacturers and software developers are accelerating the cross-pollination of hardware and analytics, resulting in integrated platforms that streamline diagnostic workflows.

At the same time, new market entrants specializing in cloud-based image management are challenging traditional installation models by offering scalable, subscription-driven access. Contrast agent producers are diversifying their portfolios to include novel tracers tailored to molecular breast imaging, while dedicated ultrasound innovators are debuting high-frequency probes and automated scan protocols that enhance throughput. Across the board, acquisition activity and licensing agreements underscore an industry-wide push to consolidate capabilities, expand geographic reach, and bolster regulatory positioning.

Crafting a Proactive Playbook for Market Leadership

Industry leaders should prioritize a multi-pronged strategy that aligns technology investments with evolving reimbursement paradigms and patient expectations. First, building modular platforms that support both on-premise and cloud-based deployment will accommodate diverse infrastructure needs and data governance requirements. Second, forging partnerships with AI specialists can expedite the integration of advanced analytics, reducing time to insight and elevating diagnostic confidence.

Third, expanding into under-served segments-whether through high-impact portable devices for remote settings or risk-adapted screening packages for different age cohorts-can open new revenue streams and deepen market penetration. Fourth, collaborating with payers and policy-makers to demonstrate the economic value of early detection will be crucial in securing favorable coverage and incentivization. Finally, embracing flexible financing models, such as equipment-as-a-service or outcome-based contracts, can alleviate capital expenditure constraints for healthcare providers while fostering long-term relationships.

Methodological Foundations Ensuring Insight Integrity

This research is grounded in a rigorous methodology that synthesizes primary interviews with leading radiologists, healthcare administrators, and technology developers alongside secondary analysis of peer-reviewed literature, regulatory filings, and industry publications. Data triangulation ensured consistency across diverse sources, while market mapping validated competitive positioning and technology adoption curves.

A comprehensive supply chain review illuminated procurement dynamics, tariff impacts, and emerging manufacturing trends. Patient pathway analysis integrated clinical guidelines and real-world utilization data to model modality preferences across demographics. The segmentation framework emerged from an iterative clustering process, balancing clinical relevance with commercial practicability. Finally, insights were stress-tested through scenario workshops with domain experts to ensure robustness and applicability across varied market conditions.

Charting the Course for Sustainable Screening Impact

The trajectory of breast cancer screening is poised at a critical inflection point, where innovation, cost considerations, and patient-centric care converge. As stakeholders navigate tariff challenges, regional disparities, and the imperative for personalized protocols, the ability to synthesize multifaceted data into clear strategic decisions will define market leadership.

By understanding the nuanced interplay of technology, age demographics, delivery modes, and end-user priorities, organizations can tailor their approaches to optimize patient outcomes while achieving sustainable growth. The insights and recommendations presented herein offer a roadmap for harnessing the full potential of advanced screening modalities and creating meaningful value across the healthcare ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • 2D Mammography
      • Analog
      • Digital
    • 3D Tomosynthesis
    • Magnetic Resonance Imaging
      • Contrast Enhanced
      • Non Contrast
    • Molecular Breast Imaging
      • Breast Specific Gamma Imaging
      • Scintimammography
    • Thermography
    • Ultrasound
      • Automated
      • Handheld
  • Age Group
    • 40 To 49
    • 50 To 69
    • 70 And Above
    • Under 40
  • Delivery Mode
    • Cloud
      • Software As A Service
      • Web Based
    • On Premise
  • End User
    • Ambulatory Care Centers
    • Clinics
      • Primary Care Clinics
      • Specialty Clinics
    • Diagnostic Centers
      • Chain Centers
      • Independent Centers
    • Hospitals
      • Private Hospitals
      • Public Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Hologic, Inc.
  • GE HealthCare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Fujifilm Holdings Corporation
  • Canon Medical Systems Corporation
  • Konica Minolta, Inc.
  • Shimadzu Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Carestream Health, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Breast Cancer Screening Market, by Technology
8.1. Introduction
8.2. 2D Mammography
8.2.1. Analog
8.2.2. Digital
8.3. 3D Tomosynthesis
8.4. Magnetic Resonance Imaging
8.4.1. Contrast Enhanced
8.4.2. Non Contrast
8.5. Molecular Breast Imaging
8.5.1. Breast Specific Gamma Imaging
8.5.2. Scintimammography
8.6. Thermography
8.7. Ultrasound
8.7.1. Automated
8.7.2. Handheld
9. Breast Cancer Screening Market, by Age Group
9.1. Introduction
9.2. 40 To 49
9.3. 50 To 69
9.4. 70 And Above
9.5. Under 40
10. Breast Cancer Screening Market, by Delivery Mode
10.1. Introduction
10.2. Cloud
10.2.1. Software As A Service
10.2.2. Web Based
10.3. On Premise
11. Breast Cancer Screening Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Clinics
11.3.1. Primary Care Clinics
11.3.2. Specialty Clinics
11.4. Diagnostic Centers
11.4.1. Chain Centers
11.4.2. Independent Centers
11.5. Hospitals
11.5.1. Private Hospitals
11.5.2. Public Hospitals
12. Americas Breast Cancer Screening Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Breast Cancer Screening Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Breast Cancer Screening Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Hologic, Inc.
15.3.2. GE HealthCare
15.3.3. Siemens Healthineers AG
15.3.4. Koninklijke Philips N.V.
15.3.5. Fujifilm Holdings Corporation
15.3.6. Canon Medical Systems Corporation
15.3.7. Konica Minolta, Inc.
15.3.8. Shimadzu Corporation
15.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
15.3.10. Carestream Health, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BREAST CANCER SCREENING MARKET MULTI-CURRENCY
FIGURE 2. BREAST CANCER SCREENING MARKET MULTI-LANGUAGE
FIGURE 3. BREAST CANCER SCREENING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BREAST CANCER SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ANALOG, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIGITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 3D TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON CONTRAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST SPECIFIC GAMMA IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SCINTIMAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY THERMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 40 TO 49, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 50 TO 69, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 70 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY UNDER 40, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE AS A SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY WEB BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CHAIN CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 76. CANADA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. CANADA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 78. CANADA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 79. CANADA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 80. CANADA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 81. CANADA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. CANADA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 83. CANADA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 84. CANADA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. CANADA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 86. CANADA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 87. CANADA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 159. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 161. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 163. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 164. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 165. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. ITALY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. ITALY BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 187. ITALY BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 188. ITALY BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 189. ITALY BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 190. ITALY BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 191. ITALY BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 192. ITALY BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 193. ITALY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. ITALY BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 195. ITALY BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 196. ITALY BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 199. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 200. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 201. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 202. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 247. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 248. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 249. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 269. QATAR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. QATAR BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 271. QATAR BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 272. QATAR BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 273. QATAR BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 274. QATAR BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 275. QATAR BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 276. QATAR BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 277. QATAR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. QATAR BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 279. QATAR BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 280. QATAR BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 283. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 284. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 285. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 286. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 287. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 288. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 289. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 291. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 292. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 317. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 318. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 319. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 320. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 321. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 322. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 323. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 324. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 325. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 327. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 328. EGYPT BREAST CANCER SCREENING MARKET SIZE,

Companies Mentioned

The companies profiled in this Breast Cancer Screening market report include:
  • Hologic, Inc.
  • GE HealthCare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Fujifilm Holdings Corporation
  • Canon Medical Systems Corporation
  • Konica Minolta, Inc.
  • Shimadzu Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Carestream Health, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.91 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Breast Cancer Diagnostics Market by Technology, Product, End User, Biomarker, Sample Type - Global Forecast to 2030 - Product Image

Breast Cancer Diagnostics Market by Technology, Product, End User, Biomarker, Sample Type - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Breast Cancer Screening Device Market - Global Forecast to 2030 - Product Image

Breast Cancer Screening Device Market - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Global Breast Cancer Screening Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Breast Cancer Screening Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • Global
From
Breast Cancer Screening - Global Strategic Business Report - Product Image

Breast Cancer Screening - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From

About the Breast Cancer Screening Market

The Breast Cancer Screening market is a key component of Women's Health. It is a preventative measure that helps to detect breast cancer in its early stages, when it is most treatable. Screening typically involves mammography, which is an X-ray imaging test that can detect changes in the breast tissue. Other screening methods include clinical breast exams, breast ultrasounds, and MRI scans. The Breast Cancer Screening market is a growing industry, with many companies offering services to women. These companies provide a range of services, from mammography to MRI scans, to help women detect breast cancer early. Companies in the Breast Cancer Screening market include Breastlink, Breast Cancer Diagnostics, and Breast Health Solutions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.